Sign In
to Vote &
Create Storyboards.
 

Analyst Moves: ABBV, CCE

Forbes - 1 Apr 2013 19:46
Abbvie (ABBV) was downgraded by BMO Capital (BMO) from outperform to market perform, as the stock price has approached the previously set $42 price target.
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard